Takeda Pharmaceutical Files 6-K Report

Ticker: TKPHF · Form: 6-K · Filed: Jul 1, 2025 · CIK: 1395064

Takeda Pharmaceutical Co Ltd 6-K Filing Summary
FieldDetail
CompanyTakeda Pharmaceutical Co Ltd (TKPHF)
Form Type6-K
Filed DateJul 1, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

TL;DR

Takeda filed a 6-K on July 1, 2025, confirming its 20-F filing status and Tokyo HQ.

AI Summary

Takeda Pharmaceutical Company Limited filed a Form 6-K on July 1, 2025, reporting information as of July 2025. The filing indicates Takeda is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive offices are located in Tokyo, Japan.

Why It Matters

This filing serves as an update for investors regarding Takeda's regulatory reporting status and corporate information, confirming its adherence to SEC requirements for foreign private issuers.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a large, established company and does not contain new financial or operational information that would typically indicate risk.

Key Players & Entities

  • Takeda Pharmaceutical Company Limited (company) — Filer of the 6-K report
  • 001-38757 (company) — SEC File Number
  • Tokyo, Japan (location) — Location of principal executive offices

FAQ

What type of SEC filing is this?

This is a Form 6-K, a Report of Foreign Private Issuer.

Who is the filer of this report?

The filer is Takeda Pharmaceutical Company Limited.

What is the reporting period for this Form 6-K?

The report is for the month of July 2025, filed as of July 1, 2025.

Under which form will Takeda file its annual reports?

Takeda indicates it files annual reports under Form 20-F.

Where are Takeda's principal executive offices located?

Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8668, Japan.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 1, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.